Caris Life Sciences Presented Research Demonstrating the Value of Whole Transcriptome Sequencing in Precision Oncology at the Association of Molecular Pathology 2026 Annual Meeting
Two Caris-led studies highlight the power of comprehensive RNA sequencing to identify novel and rare gene fusions across solid tumors IRVING, Texas, Nov. 16, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer,...